{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T22:38:51Z","timestamp":1720564731906},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.mehy.2016.09.017","type":"journal-article","created":{"date-parts":[[2016,9,24]],"date-time":"2016-09-24T17:26:31Z","timestamp":1474737991000},"page":"16-19","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Endogenous erythropoietin and erythropoietin receptors in colorectal cancer; can we answer the questions?"],"prefix":"10.1016","volume":"96","author":[{"given":"Aleksandar","family":"\u010cubrani\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Dobrila-Dintinjana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnela","family":"Red\u017eovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marijan","family":"Dintinjana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Du\u0161ka","family":"Petranovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marin","family":"Gol\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2016.09.017_b0005","first-page":"4163","article-title":"Clinicopathological significance of p 53, hypoxia-inducible factor 1 alpha and vascular endothelial growth factor expression in colorectal cancer","volume":"30","author":"Kwon","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.mehy.2016.09.017_b0010","first-page":"215","article-title":"Expression of erythropoietin in human female reproductive organs","volume":"106","author":"Yasuda","year":"2001","journal-title":"Ital J Anat Embryol"},{"key":"10.1016\/j.mehy.2016.09.017_b0015","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.mehy.2013.09.030","article-title":"The role of erythropoietin and erythropoietin receptor in malignant laryngeal tumors","volume":"81","author":"Vukeli\u0107","year":"2013","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2016.09.017_b0020","article-title":"Cancer statistics, 2007","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.mehy.2016.09.017_b0025","first-page":"38","article-title":"Does erythropoietin have a dark side? Epo signaling and cancer cells","volume":"395","author":"Sytkowski","year":"2007","journal-title":"Sci STKE"},{"key":"10.1016\/j.mehy.2016.09.017_b0030","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P","article-title":"Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review","volume":"91","author":"Caro","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.mehy.2016.09.017_b0035","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ejca.2006.10.012","article-title":"Preclinical studies of erythropoietin receptor expression in tumor cells: impact on clinical use of erythropoietic proteins to correct cancer-related anaemia","volume":"43","author":"\u04e6sterborg","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.mehy.2016.09.017_b0040","doi-asserted-by":"crossref","DOI":"10.1177\/1066896908315796","article-title":"Erythropoetin receptor in colorectal cancer","author":"Chabowska","year":"2008","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.mehy.2016.09.017_b0045","article-title":"Prognostic significance of erythropoetin and erythropoetin receptor in gastric adenocarcinoma","author":"Lin","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.mehy.2016.09.017_b0050","unstructured":"Ministarstvo zdravstva i socijalne skrbi Republike Hrvatske. Nacionalni program ranog otkrivanja raka debelog crijeva, Zagreb, <http:\/\/www.izlog.info\/tmp\/hcjz\/clanak.php?id=14259>; 2007 [accessed 7 Oct 2011]."},{"issue":"Suppl. 5","key":"10.1016\/j.mehy.2016.09.017_b0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1634\/theoncologist.9-90005-18","article-title":"The erythropoietin receptor and its expression in tumor cells and other tissues","volume":"9","author":"Farell","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.mehy.2016.09.017_b0060","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/cncr.10787","article-title":"Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma","volume":"95","author":"Acs","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.mehy.2016.09.017_b0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jss.2007.05.041","article-title":"Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer","volume":"147","author":"Zafirellis","year":"2008","journal-title":"J Surg Res"},{"key":"10.1016\/j.mehy.2016.09.017_b0070","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<2013::AID-CNCR8>3.0.CO;2-R","article-title":"Frequency and clinical features of multiple tumorous of the large intestine bowel in the general population and in patients with hereditary colorectal carcinoma","volume":"77","author":"Fante","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.mehy.2016.09.017_b0075","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrc1453","article-title":"Genetic predisposition to colorectal cancer","volume":"4","author":"La Chapelle","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.mehy.2016.09.017_b0080","unstructured":"Cancer research UK. <www.cancerresearchuk.org>; 2002 [accessed 7 Sep 2015]."},{"key":"10.1016\/j.mehy.2016.09.017_b0085","first-page":"4033","article-title":"Erythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis","volume":"8","author":"Zhihong","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.mehy.2016.09.017_b0090","doi-asserted-by":"crossref","DOI":"10.1172\/JCI69804","article-title":"Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal","author":"Zhou","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2016.09.017_b0095","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cgh.2005.12.021","article-title":"Prevalence of clinically important histology in small adenomas","volume":"4","author":"Butterly","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.mehy.2016.09.017_b0100","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Eng J Med"},{"key":"10.1016\/j.mehy.2016.09.017_b0105","first-page":"2020","article-title":"Quasar collaborative group adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study","volume":"307","author":"Gray","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.mehy.2016.09.017_b0110","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/hp.2000.6724","article-title":"Angiogenesis as a predictor of clinical outcome in cancer patients","volume":"31","author":"Weidner","year":"2000","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.mehy.2016.09.017_b0115","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1469-7580.1997.19130367.x","article-title":"Immunohistochemical methods for semiquantitative analysis of collagen content in human peripheral nerve","volume":"191","author":"Lovry","year":"1997","journal-title":"J Anat"},{"key":"10.1016\/j.mehy.2016.09.017_b0120","series-title":"Methods in molecular biology","first-page":"361","author":"Amriovi\u0107 Ristov","year":"2007"},{"key":"10.1016\/j.mehy.2016.09.017_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2008.03.006","article-title":"The erythropoetin receptor in normal and cancer tissue","author":"Jel kmann","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.mehy.2016.09.017_b0130","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-12-194","article-title":"Clinical significance of erythropoietin receptor expression in oral squamous cell carcinoma","author":"Lin","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.mehy.2016.09.017_b0135","doi-asserted-by":"crossref","DOI":"10.4103\/0377-4929.81591","article-title":"Expression of erythropoetin and its receptor increases in colonic neoplastic progression: the role of hypoxia in tumorangiogenesis","author":"Gombos","year":"2011","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.mehy.2016.09.017_b0140","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.2353\/ajpath.2010.090972","article-title":"HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers","volume":"176","author":"Baba","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.mehy.2016.09.017_b0145","first-page":"680","article-title":"HIF-1\u03b1 in colorectal carcinoma: review of the literature","volume":"20","author":"Ioannou","year":"2015","journal-title":"JBUON"},{"key":"10.1016\/j.mehy.2016.09.017_b0150","doi-asserted-by":"crossref","DOI":"10.1007\/s00384-009-0798-8","article-title":"Erythropoietin production caused by metastatic colon cancer","author":"Ban","year":"2010","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.mehy.2016.09.017_b0155","first-page":"585","article-title":"Mystery story about erythropoietin (Epo) and erythropoietin receptor (EpoR) are disguised?","volume":"62","author":"\u010cubrani\u0107","year":"2015","journal-title":"Hepatogastroenterology"},{"issue":"2","key":"10.1016\/j.mehy.2016.09.017_b0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.mph.0000153441.34407.d9","article-title":"Erythropoietin levels in children and adolescents with inflammatory bowel disease","volume":"27","author":"Tsitsika","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"10.1016\/j.mehy.2016.09.017_b0165","first-page":"1197","article-title":"Management of iron deficiency anemia in inflammatory bowel disease a practical approach","volume":"26","author":"Stein","year":"2013","journal-title":"Ann Gastroenterol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716301542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716301542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T00:01:49Z","timestamp":1536364909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987716301542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":33,"alternative-id":["S0306987716301542"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2016.09.017","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endogenous erythropoietin and erythropoietin receptors in colorectal cancer; can we answer the questions?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2016.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}